- Founded
- 2016
- Business Model
- B2B
- Website
- beit.tech
About
Technology platform for compliant, cost-effective 3D printing of personalized medicines in pharmacies.
Summary
BEIT is a Biotech company, founded in 2016.
Similar Companies
AsymchemIPO
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Tianjin, China5001–10000Healthcare, Biotech
Private Equity·$2.3B·Feb 2020
Abogen Biosciences
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Suzhou, China201–500Biotech, mRNA Therapeutics
Extension Round·$1.3B·Nov 2021
Eikon TherapeuticsIPO
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Hayward, United States201–500Artificial Intelligence, Biotech
Series D·$1.1B·Feb 2025
Treeline Biosciences
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Watertown, United States51–200Biotech, Drug Discovery
Extension Round·$821.8M·Sep 2025
Enveda Biosciences
Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...
Boulder, United States201–500Artificial Intelligence, Biotech
Series D·$740.0M·Sep 2025
FogPharma
Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...
Cambridge, United States51–200Biotech, Drug Discovery
Series F·$694.0M·Jan 2025